Get the Stockscreener App
2.03
0.49%
-0.01
Tiziana Life Sciences Ltd stock is traded at $2.03, with a volume of 28,609.
It is down -0.49% in the last 24 hours and up +20.12% over the past month.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
See More
Previous Close:
$2.04
Open:
$2.05
24h Volume:
28,609
Relative Volume:
0.07
Market Cap:
$237.20M
Revenue:
-
Net Income/Loss:
$-13.73M
P/E Ratio:
-15.62
EPS:
-0.13
Net Cash Flow:
$-3.92M
1W Performance:
+3.05%
1M Performance:
+20.12%
6M Performance:
+156.93%
1Y Performance:
+115.93%
1-Day Range:
$2.00
$2.1133
1-Week Range:
$1.91
$2.33
52-Week Range:
$0.6295
$2.60
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
Name
Tiziana Life Sciences Ltd
Sector
Industry
Phone
-
Address
-
Compare TLSA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLSA
Tiziana Life Sciences Ltd
|
2.03 | 242.40M | 0 | -13.73M | -3.92M | -0.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.42 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.45 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.17 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.67 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
326.40 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-22-20 | Initiated | B. Riley Securities | Buy |
| Dec-17-18 | Initiated | Laidlaw | Buy |
Tiziana Life Sciences Ltd Stock (TLSA) Latest News
Can Tiziana Life Sciences Ltd stock outperform in 2025 bull marketDividend Hike & Safe Capital Growth Plans - newser.com
What high frequency data says about Tiziana Life Sciences LtdWeekly Gains Report & Weekly Market Pulse Alerts - newser.com
Will Tiziana Life Sciences Ltd stock recover faster than marketMarket Risk Analysis & Weekly High Return Opportunities - newser.com
What Wall Street predicts for Tiziana Life Sciences Ltd stock priceWeekly Profit Report & High Accuracy Swing Entry Alerts - newser.com
Heatmap analysis for Tiziana Life Sciences Ltd and competitors2025 Volume Leaders & Daily Risk Controlled Trade Plans - newser.com
Building trade automation scripts for Tiziana Life Sciences LtdJuly 2025 Review & Fast Gaining Stock Reports - newser.com
Can volume confirm reversal in Tiziana Life Sciences Ltd2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
Detecting price anomalies in Tiziana Life Sciences Ltd with AIPortfolio Value Report & Stepwise Trade Execution Plans - newser.com
Weiss Ratings Reiterates "Sell (D-)" Rating for Tiziana Life Sciences (NASDAQ:TLSA) - MarketBeat
Is Tiziana Life Sciences Ltd meeting your algorithmic filter criteria2025 AllTime Highs & Weekly Top Gainers Trade List - newser.com
What’s next for Tiziana Life Sciences Ltd stock priceJuly 2025 Movers & Safe Capital Growth Trade Ideas - newser.com
What insider trading reveals about Tiziana Life Sciences Ltd stockQuarterly Market Review & Comprehensive Market Scan Reports - newser.com
Tiziana Life Sciences Reports Interim Results and Expands U.S. Presence - TipRanks
Tiziana Life Sciences Ltd stock daily chart insights2025 Winners & Losers & Free Community Supported Trade Ideas - newser.com
Is Tiziana Life Sciences Ltd stock reversal real or fakeWeekly Loss Report & Fast Exit and Entry Trade Guides - newser.com
Tiziana Life Sciences to showcase drug candidate at Saudi innovation forum - Proactive financial news
Global Biotech Innovation Showcase: Tiziana Life Sciences Joins Elite Companies at Saudi LSIF 2025 - Stock Titan
About Us - FinancialContent
What analysts say about Tiziana Life Sciences Ltd stockTake Profit Strategies & Small Capital Trading Growth - earlytimes.in
What drives Tiziana Life Sciences Ltd stock priceStock Watchlist Updates & Get Tomorrow’s Winners Today With AI - earlytimes.in
Can Patspin India Limited Continue Delivering AboveAverage ReturnsBreakout Stock Watch & Fast Growing Investment Ideas - earlytimes.in
Tiziana Life Sciences (NASDAQ:TLSA) Stock Price Down 0.5%Should You Sell? - MarketBeat
Tiziana plans to develop IL-6R monoclonal antibody TZLS-501 - BioWorld MedTech
Small cap wrap: Trust Stamp, Algernon Health, Immunic... - Proactive Investors
Market movers: Gunnison Copper, Tiziana Life Sciences, Seeing Machines... - Proactive financial news
Tiziana Life Sciences stock higher on inflammatory therapy plans - Proactive financial news
Tiziana Life Sciences (TLSA) Advances Anti-Inflammatory Therapy - GuruFocus
How to read the order book for Tiziana Life Sciences LtdJuly 2025 Analyst Calls & Real-Time Stock Price Movement Reports - newser.com
Tiziana to Advance TZLS-501Its Fully Human IL-6R Monoclonal Antibody - The Manila Times
$1.4B Novartis Deal Sparks Tiziana's Advanced Push of Dual-Action IL-6R Antibody for Inflammatory Disease - Stock Titan
Tiziana Life Sciences Ltd Stock (TLSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.20%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):